Beauvoir C, Rochette A, Desch G, D'Athis F
Service d' Anesthésie-Réanimation A, Hôpital Lapeyronie, Montpellier, France.
Paediatr Anaesth. 1996;6(3):195-9. doi: 10.1111/j.1460-9592.1996.tb00428.x.
This study was designed to measure total and free bupivacaine (B) after spinal anaesthesia in newborns and to evaluate a possible influence of adrenaline on B absorption. Twenty-two newborns were randomly allocated to receive either plain B (group 1) or adrenaline added to B (group 2) for spinal anaesthesia. A single blood sample was collected ten min after spinal injection. Total B concentration was found 0.31 +/- 0.17 microgram ml-1 in group 1 and 0.25 +/- 0.09 microgram ml-1 in group 2. Bound B concentration was 0.27 +/- 0.17 microgram ml-1 in group 1 and 0.22 +/- 0.09 microgram ml-1 in group 2. No difference was found between the two groups for these parameters. Albumin but not alpha 1-acid-glyco-protein correlated to age and weight, bound B correlated to alpha 1-acid-glyco-protein but not to albumin. Despite the low plasma concentration of binding proteins in newborns, spinal anaesthesia with B does not result in a high level of free drug. Adrenaline does not have any pharmacological advantage in these patients.
本研究旨在测定新生儿脊髓麻醉后布比卡因的总量和游离量,并评估肾上腺素对布比卡因吸收的可能影响。22例新生儿被随机分为两组,一组接受单纯布比卡因用于脊髓麻醉(第1组),另一组接受加入肾上腺素的布比卡因用于脊髓麻醉(第2组)。脊髓注射后10分钟采集一份血样。第1组总布比卡因浓度为0.31±0.17微克/毫升,第2组为0.25±0.09微克/毫升。第1组结合布比卡因浓度为0.27±0.17微克/毫升,第2组为0.22±0.09微克/毫升。两组在这些参数上未发现差异。白蛋白与年龄和体重相关,而α1-酸性糖蛋白不相关;结合布比卡因与α1-酸性糖蛋白相关,与白蛋白不相关。尽管新生儿血浆中结合蛋白浓度较低,但布比卡因脊髓麻醉不会导致游离药物水平升高。肾上腺素在这些患者中没有任何药理学优势。